We are live on
!
Find out more
PBMWW
Psyence Biomedical Warrant
PBMWW
PBMWW
28 hedge funds and large institutions have $75.6K invested in Psyence Biomedical Warrant in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
7% less funds holding
Funds holding: 30 → 28 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
85% less capital invested
Capital invested by funds: $514K → $75.6K (-$439K)
Holders
28
Holders Change
-2
Holders Change %
-6.67%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
3
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
–
Top Buyers
| 1 |
CAC
Cowen and Company
New York
|
+$57.8K |
| 2 |
Goldman Sachs
New York
|
+$11.1K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$677 |
Top Sellers
| 1 |
EFI
EHP Funds Inc
Toronto,
Canada
|
-$86.3K |
| 2 |
MSU
Mizuho Securities USA
New York
|
-$4.47K |
| 3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$4.17K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.7K |